Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KalVista
Biotech
BioCryst ends internal programs in pivot to partnerships
BioCryst is shuttering all internal discovery programs to focus on external innovation and partnerships.
Will Maddox
Jun 29, 2026 10:30am
FDA's 'heavy workload' blamed for delaying KalVista's PDUFA date
Jun 16, 2025 4:33am
KalVista sells Japanese rights for HAE drug to Kaken
Apr 8, 2025 8:35am
KalVista's persistence with sebetralstat pays off in ph. 3 win
Feb 13, 2024 6:30am
KalVista axes angioedema program over raised enzyme levels
Oct 4, 2022 10:32am
KalVista bulks up executive team with CMO addition
May 3, 2021 8:00am
